Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Wales to consult on BVD eradication scheme
The current voluntary scheme has seen more than 80 per cent of Wales' cattle herd screened for BVD.

The scheme aims to eliminate Persistently Infected animals from Welsh herds.

The Welsh Government is to consult on proposals for a compulsory scheme to eradicate Bovine Viral Diarrhoea (BVD) in the country.

Under the scheme, cattle keepers would be required to test their herds annually for BVD and take steps to isolate Persistently Infected (PI) animals. Herds that test positive will be subject to movement restrictions until they are clear. 

The scheme aims to eliminate PI animals from Welsh herds, which will eventually lead to the disease's progressive extinction. In other regions of the United Kingdom, similar programmes are either being planned or are already in existence. 

A current voluntary scheme, due to end in early 2023, has seen more than 80 per cent of Wales' cattle herd screened for BVD. However, PI's under this scheme do not need to be removed from the herd and can be sold on. 

Rural affairs minister Lesley Griffiths urged cattle keepers and anyone with an interest in the dairy and beef industries to participate in the consultation. 

“We already have a very high take-up in the voluntary BVD scheme in Wales, and the next step to completely eradicate this disease here is to consider making the scheme compulsory,” she said. “As a result of the high take up of the voluntary scheme, many cattle keepers will be familiar with the requirements of testing.

“Eradicating the disease will improve animal health and welfare and improve productivity on the farm.”

For more information and to take part in the consultation, visit gov.wales

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.